Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up

Tue, 05th Apr 2022 21:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Alpha FX Group PLC - London-based foreign exchange risk management and international payments - Restarts trading relationship with unnamed "key" Norwegian client. Entered settlement agreement with client in March 2020 at onset of Covid pandemic, where the client was required to make weekly repayments until June 2022 in respect of their obligations for unpaid margins. "Since this date, the client's financial standing has continued to strengthen, and they have consistently met all 104 of their weekly repayment obligations on time. As a result, the gross balance outstanding as at April 1, 2022 has been reduced to GBP2.9 million," company says. Notes it will allow clients to pay outstanding amount over rest of 2022, extending deadline past June 2022.

----------

Marlowe PLC - London-based company focused on business safety and regulatory compliance - Says at Capital Markets Day its trading has been "strong" and expects to meet 2024 strategic and financial targets "materially ahead of schedule". Company says the "significant development" in building its compliance platform - which now encompasses intelligence, consultancy, software and assurance - the reason behind strong trading.

----------

Aferian PLC - Leeds-based video streaming - Acquires 100% share capital of Exabre Ltd, trading as The Filter, a UK-headquartered AI-powered video recommendation service. Initial consideration of deal will GBP1.5 million in cash, with up to GBP2.5 million subject to achieving certain annual recurring revenue growth at increments of additional ARR of GBP500,000. Company says: "The Filter's technology will significantly accelerate the roadmap of 24i's video streaming platform by adding enhanced analytics, recommendations and personalisation to its existing data analytics services. 24i will also market The Filter's managed service solution to its existing OTT and Pay TV customers and prospects as a standalone service."

----------

Glantus Holdings PLC - Dublin-based accounts payable automation and analytics - Agrees new partnership with TealBook, a supplier data firm that powers e-procurement technology. "This partnership will enable customers of both parties to access robust supplier information and insights and stronger AP intelligence," company explains. Adds: "The referral party vendor and supplier information through TealBook's comprehensive supplier intelligence capabilities will enable TealBook customers to utilize the Glantus data analytics solution to understand opportunities for efficiency and risk mitigation within their AP operations and payments."

----------

Redx Pharma PLC - Cheshire-based cancer and fibrosis drug developer - Agrees collaboration with the Garvan Institute of Medical Research, an Australian medical research institute, which expands on company's preclinical work already underway. "The collaboration aims to better understand treatments that could lead to increased patient survival in currently very poorly treated highly fibrotic cancers, such as pancreatic cancer," company says. Adds: "Through this collaboration, Redx and the Garvan will develop an enhanced understanding of cancer-associated fibrosis through detailed scientific studies utilising patient-derived tumour tissue grown in mice, which is thereby able to mimic human disease as closely as possible."

----------

e-Therapeutics PLC - Oxford, England-based computational drug discovery - Enters research collaboration agreement with iTeos Therapeutics Inc, a clinical-stage biopharmaceutical company focused on discovery and development of a new generation of immuno-oncology therapeutics. "The collaboration will focus on the discovery of novel therapeutic approaches and targets in immuno-oncology. e-therapeutics will remain free to explore additional collaborations in the space," company explains. e-therapeutics will receive upfront and near-term cash payments material to the revenue of the company.

----------

Atalaya Mining PLC - copper miner in Spain - Sees "significant" increase in mineral resources at Proyecto Masa Valverde. PMV is located in the Iberian Pyrite Belt of southern Spain. PMV consists of two deposits, Masa Valverde and Majadales. Sees increase in tonnage and contained copper, silver and gold from prior estimate of 42%, 33%, 26% and 34%, respectively. Masa Valverde initial indicated mineral resource now 16.9 million tonnes at 0.66% copper, 1.55% zinc, 0.65% lead, and 27 grammes per tonne silver and 0.55 grammes per tonne gold. Chief Executive Alberto Lavandeira says: "We remain excited about the continued exploration potential at PMV, given the many anomalies our exploration team has identified. We hope to make further discoveries, building on our success in discovering the Majadales deposit, which is shallower and higher grade than Masa Valverde and thus may play a key role in optimising future development scenarios."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Nov 2018 12:52

Redx Pharma Showcases Positive Preclinical Trial Results Of RXC004

LONDON (Alliance News) - Redx Pharma PLC on Monday reported a positive data from preclinical studies evaluating RXC004.The results were presented at the National Cancer Research Institute a

Read more
29 Oct 2018 14:50

Redx CEO Lisa Anson elected to Bioindustry Association board

(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected to serve on the BIA board of directors.

Read more
24 Apr 2018 11:17

Redx Pharma Hires AstraZeneca UK President As Chief Executive

LONDON (Alliance News) - Shares jumped in Redx Pharma PLC on Tuesday as it announced the appointment of AstraZeneca PLC executive Lisa Anson as chief executive officer with effect on June in the I

Read more
22 Mar 2018 13:43

Redx Pharma Signs Agreement For Anti-Infective Programme With Deinove

LONDON (Alliance News) - Drug development company Redx Pharma PLC said Thursday that it has signed an option and licence agreement with chemicals company Deinove SAS for Novel

Read more
9 Feb 2017 14:21

RedX Pharma as it proposes discounted capital raising

(ShareCast News) - Shares in RedX Pharma are down almost 5% as it proposes raising £12m, before expenses, via a placing and subscription to advance its drugs pipeline. The proposed placing was of up to 20.5m shares, while the subscription was of 11.5m shares by Lanstead Capital, an institutional inv

Read more
30 Nov 2016 10:13

Redx Pharma To Present Pre-Clinical Profile Of RXC004 At Conference

Read more
20 Oct 2016 11:34

Redx Pharma identifies candidate for inhibitor programme

(ShareCast News) - Drug-development company Redx Pharma has identified a candidate for its reversible Bruton's tyrosine kinase (BTK) inhibitor programme. The compound, named RXC005, has the potential to treat the majority of patients suffering from chronic lymphocytic leukaemia (CLL), including tho

Read more
20 Oct 2016 08:33

Redx Pharma Selects Drug Candidate To Treat Leukaemia

Read more
27 Sep 2016 09:33

WINNERS & LOSERS SUMMARY: Wolseley Sold Amid Job Cuts, No Extra Payout

Read more
19 Sep 2016 08:13

Redx Pharma Sees Cancer Immunotherapy Promise For Porcupine Inhibitor

Read more
11 Sep 2016 15:25

Sunday share tips: Dunelm Group, Green REIT, Redx Pharma

(ShareCast News) - Buy shares in Dunelm Group, said the Sunday Times' Inside the City column. On Wednesday the home furnishings retailer is due to publish its first annual results under new chief executive John Browett. In the final three months of the year the FSTE 250 company - a sort of cut-price

Read more
24 May 2016 09:33

Redx Pharma Loss Widens But Notes Oncology Lead Progress

Read more
19 May 2016 10:17

Redx Pharma Welcomes Paper On Tackling Antimicrobial Resistance

Read more
9 May 2016 07:46

Redx Pharma Appoints David Lawrence Non-Executive Director

Read more
24 Mar 2016 14:08

Redx Pharma Raising GBP10.0 Million To Progress Its Pipeline (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.